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Editorial comment: As shown in previous stereotactic electrical stimulation studies in the rat, the hypothalamic medial preoptic area (MPOA) represents an important supraspinal control site for complex urogenital responses including penile erection. In advancing some of their pioneering work in the neurophysiology of penile erection, the investigators have precisely explored peripheral neural pathways activated by MPOA stimulation that in¯uence local mechanisms of penile erection. Erectile responses elicited by MPOA stimulation were investigated following lesioning of various neural ®ber distributions in the pelvis. These responses were abolished by acute bilateral section of cavernous or pelvic nerves or cauda equina and by chronic section of pelvic nerves or cauda equina, af®rming the proerectile role of the parasympathetic neural pathways. Erectile responses were not signi®cantly altered by acute section of the hypogastric nerve, challenging the notion that this sympathetic neural distribution substantially contributes a proerectile input to penile erection (insofar as the rat model). Remarkably, erectile responses were signi®-cantly depressed after acute or chronic sections of the paravertebral sympathetic chain at the L4±L5 level or chemical sympathectomy with 6-hydroxydopamine, an effect which was reversed by bilateral ligation of the external iliac arteries. The latter results were explained as a proerectile regulatory role for sympathetic ®bers coursing in the paravertebral sympathetic chain producing vasoconstriction of the nonpenile pelvis vascular supply, thereby shunting blood to the erectile tissue. These results, taken together, provide evidence for parasympathetic lumbosacral and lumbosacral paravertebral sympathetic chain neural pathways that carry out the control of the erectile response provided by the MPOA. This work suggests that the MPOA exerts an integrative proerectile in¯uence, recruiting both parasympathetic and sympathetic spinal nuclei that participate in the local control of penile erection. Further experiments are anticipated to de®ne supraspinal and spinal pathways coordinating the activation of these autonomic out¯ows upon electrical stimulation of the MPOA. Editorial comment: The importance of nitric oxide (NO) as the likely principal inhibitory neurotransmitter of penile erection has been reasonably well established, with ample experimental studies con®rming the effects of this chemical on erectile tissue smooth muscle relaxation in vitro and in vivo and its localization to nerve ®bers supplying the penis in various species. These investigators have further sought to evaluate mechanisms involving NO in penile erection and erectile dysfunction with a comprehensive pharmacological investigation of the NO pathway in the pelvic nerve-stimulated erection, anesthetized dog model. N G -nitro-L-arginine, a NO synthase inhibitor, dose dependently attenuated erections, with a 10-fold greater potency when applied intracavernously than intravenously. Subsequent intravenous and intracavernous administrations of L-arginine, the NO precursor, but not its stereoisomer D-arginine, restored the pelvic nervestimulated response. These results were understood to support the role of NO in penile erections, with a potent local effect. Intracavernously administered N G , N G -dimethylarginine, an endogenous NO synthase inhibitor, known to accumulate in the plasma of patients with chronic renal failure, also dose dependently attenuated erectile responses, and this inhibition was reversed by intracavernous administration of L-arginine. However, since the effective antagonistic doses of the endogenous NOS inhibitor was shown to be 10-fold greater than expected circulating concentrations, it was concluded that this factor is unlikely to participate in the genesis of erectile dysfunction. Erectile responses were abolished with the intravenous injection of hexamethonium, whereas they were not signi®cantly altered with the intravenous injection of phentolamine and atropine. These results suggested that pelvic nerve-stimulated erectile responses involves the stimulation of action potentials in preganglionic nerve ®bers that activate nicotinic receptors in postganglionic NO-containing nerves innervating the corpus cavernosum and is not potentiated by aadrenoceptor blockade or mediated by muscarinicreceptor activation. This investigation provides support for mechanisms of NO release in the penis, although more work is needed to establish the regulatory basis for its effects in both normal erection and erectile dysfunction as well as its interaction with other erectile co-mediators.
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